BioLife Solutions Inc
NASDAQ:BLFS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioLife Solutions Inc
NASDAQ:BLFS
|
US |
|
Banco Bilbao Vizcaya Argentaria SA
MAD:BBVA
|
ES |
|
Isetan Mitsukoshi Holdings Ltd
F:4HP
|
JP |
|
Adicet Bio Inc
NASDAQ:ACET
|
US |
|
C
|
ChipMOS Technologies Inc
F:CPIA
|
TW |
|
O
|
Olin Corp
SWB:OLN
|
US |
|
Holcim AG
OTC:HCMLY
|
CH |
|
M
|
Moderna Inc
F:0QF
|
US |
|
N
|
Next PLC
OTC:NXGPY
|
UK |
|
T
|
Transocean Ltd
BMV:RIGN
|
CH |
|
H
|
Henry Schein Inc
LSE:0L3C
|
US |
|
I
|
Industrial and Commercial Bank of China Ltd
SWB:ICK
|
CN |
|
H
|
Helmerich and Payne Inc
F:HPC
|
US |
|
B
|
Boston Scientific Corp
SWB:BSX
|
US |
|
Cbrain A/S
CSE:CBRAIN
|
DK |
|
F
|
Floor & Decor Holdings Inc
F:1FD
|
US |
|
B
|
Biomarin Pharmaceutical Inc
F:BM8
|
US |
|
B
|
Boston Scientific Corp
XMUN:BSX
|
US |
|
F
|
Fresenius SE & Co KGaA
F:FRE
|
DE |
|
NN Group NV
AEX:NN
|
NL |
|
Fox Corp
NASDAQ:FOXA
|
US |
|
H
|
Hartford Financial Services Group Inc
F:HFF
|
US |
|
Luca Mining Corp
XTSX:LUCA
|
CA |
|
International Paper Co
NYSE:IP
|
US |
Wall St Price Targets
BLFS Price Targets Summary
BioLife Solutions Inc
According to Wall Street analysts, the average 1-year price target for
BLFS is 31.75 USD with a low forecast of 30.3 USD and a high forecast of 34.65 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BLFS's stock price target?
Price Target
31.75
USD
According to Wall Street analysts, the average 1-year price target for
BLFS is 31.75 USD with a low forecast of 30.3 USD and a high forecast of 34.65 USD.
What is the Revenue forecast for BioLife Solutions Inc?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 8 years is 23%.
What is the Gross Profit forecast for BioLife Solutions Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 2 years is 21%.